Nancy Denyes, General Counsel at aTYR Pharma Inc. ($ATYR), made one open market sale of common shares in the last year, totaling $1,091. Her most recent sale occurred on February 4, 2026. This places her 11,544th out of 11,678 insiders by sales value, well below the average of $8.6 million across 6.4 transactions per insider. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | aTYR PHARMA INC | $ATYR | DENYES NANCY | General Counsel | S | Common Stock | 1118 | $0.98 | 33,124.0000 | 97,986,634 | 3.26% | 0.00% |
| Feb. 3, 2026 | aTYR PHARMA INC | $ATYR | DENYES NANCY | General Counsel | M | Common Stock | 2687 | $0.00 | 34,242.0000 | 97,986,634 | 8.52% | 0.00% |
| Feb. 3, 2026 | aTYR PHARMA INC | $ATYR | DENYES NANCY | General Counsel | M | Restricted Stock Unit | 2687 | $0.00 | 0.0000 | 97,986,634 | 100.00% | 0.00% |
| Jan. 9, 2026 | aTYR PHARMA INC | $ATYR | DENYES NANCY | General Counsel | A | Employee Stock Options (right to buy) | 412500 | $0.00 | 412,500.0000 | 97,986,634 | 9999.99% | 0.42% |
| Feb. 3, 2025 | aTYR PHARMA INC | $ATYR | DENYES NANCY | General Counsel | M | Common Stock | 2687 | $0.00 | 27,454.0000 | 0 | 10.85% | 0.00% |
| Feb. 4, 2025 | aTYR PHARMA INC | $ATYR | DENYES NANCY | General Counsel | S | Common Stock | 899 | $3.78 | 26,555.0000 | 0 | 3.27% | 0.00% |
| Feb. 3, 2025 | aTYR PHARMA INC | $ATYR | DENYES NANCY | General Counsel | M | Restricted Stock Unit | 2687 | $0.00 | 2,687.0000 | 0 | 50.00% | 0.00% |
| Jan. 8, 2025 | aTYR PHARMA INC | $ATYR | DENYES NANCY | General Counsel | A | Employee Stock Option (right to buy) | 275000 | $0.00 | 275,000.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | aTYR PHARMA INC | $ATYR | DENYES NANCY | General Counsel | P | Common Stock | 5000 | $1.86 | 22,267.0000 | 0 | 28.96% | 0.00% |
| Feb. 5, 2024 | aTYR PHARMA INC | $ATYR | DENYES NANCY | General Counsel | M | Restricted Stock Unit | 2688 | $0.00 | 5,374.0000 | 0 | 33.34% | 0.00% |
| Feb. 5, 2024 | aTYR PHARMA INC | $ATYR | DENYES NANCY | General Counsel | M | Common stock | 2688 | $0.00 | 14,767.0000 | 0 | 22.25% | 0.00% |
| Jan. 5, 2024 | aTYR PHARMA INC | $ATYR | DENYES NANCY | General Counsel | A | Employee Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |